key: cord-0719168-ks0xv88j authors: Zhuang, Guilong; Ou, Xueting; Zhou, Liyang; Pan, Xingfei; Li, Guohang title: Repeatedly laboratory testing SARS-CoV-2 is necessary to diagnose COVID-19 date: 2021-07-20 journal: J Infect Public Health DOI: 10.1016/j.jiph.2021.07.008 sha: 6b68eadd5b0887fc24821a9f4a17fb9d71924707 doc_id: 719168 cord_uid: ks0xv88j The pandemic of corona virus disease 2019 (COVID-19) caused by SARS-CoV-2 is ravaging the world. Diagnosis and isolation of persons who are infected with SARS-CoV-2 is very important medical emergency to contain the epidemic of COVID-19. To date, the diagnosis of COVID-19 is mainly depending on positive quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) results for SARS-CoV-2. In the present study, we reported that two cases with uncommon symptoms from a family cluster were ultimately diagnosed as COVID-19 after more than twice of collecting samples and qRT-PCR tests were done. It is easily to miss diagnosis of COVID-19 especially for patients with uncommon symptoms. More attention should be paid to observe the clinical characteristics of it and invent more accurate and convenient methods to detect SARS-CoV-2 as soon as possible. To the editor: Since December 2019, corona virus disease 2019 (COVID-19), caused by SARS-CoV-2, has been spread to a lot of countries in the world [1] [2] [3] . On Jan 30, 2020, the World Health Organization (WHO) announced that the epidemic of COVID-19 is a public health emergency of international concern. In order to control the spread of SARS-CoV-2 infection as soon as possible, diagnosing and isolating patients with COVID-19 is the most important medical emergency. Nowadays, the diagnosis of COVID-19 is depending on quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) positive for SARS-CoV-2 4 . Here, we reported that two cases with uncommon symptoms from a family cluster were ultimately diagnosed as COVID-19 after more than twice collecting samples and qRT-PCR tests were done ( Figure 1 ). We obtained the written consent from the patients to publish the piece. Computed-tomography (CT) scans of the chest showed bilateral multiple lobular and subsegmental ground-glass opacity and consolidation ( Figure 2 ). Then he was hospitalized. Blood routine tests showed that white blood cell were normal and lymphocyte counts were not decreased (Table 1) . Nasopharyngeal swabs were collected twice (on Feb 1, 3, respectively) and both were negative for SARS-CoV-2 tested by qRT-PCR. As a result, he was diagnosed as community-acquired pneumonia J o u r n a l P r e -p r o o f (CAP), acute enteritis and treated with antibiotics. Several days later, he felt well and was out of hospital on Feb 4. Then he was isolated at home. On Feb 5, he had dry cough, no fever and shortness of breath. On Feb 8, he was admitted to fever clinic again. Compared with Chest CT images on Feb 2, Chest CT images on Feb 8 were severer ( Figure 2 ). Then he was hospitalized again. Blood routine tests showed that white blood cells counts were normal and lymphocyte counts were not decreased (Table 1 ). Nasopharyngeal swabs were collected twice (on Feb 8, 10, respectively) and only one (on (Figure 4) . Furthermore, blood routine tests (on Feb 11) showed that white blood cell counts were normal and lymphocyte counts were not decreased (Table 1) . However, nasopharyngeal swabs were collected seven times (on Feb 11, 12, 13, 14, 15, 16, 17, respectively) and none was positive for SARS-CoV-2 tested by qRT-PCR. Then the patient was diagnosed as community-acquired pneumonia (probably caused by virus), and was isolated in the hospital. He was administrated with oseltamivir and supportive therapy. On Feb 16, 2020, chest CT images were same as that of CT images on Feb 11. On Feb 20, 2020, CT scans of the chest was tested again and showed that chest CT images became better than that of chest CT tested on Feb 16, 2020 (Figure 4 ). Then he was excluded from COVID-19. Collecting nasopharyngeal swab sample is still the most common and economic method used to test gene of SARS-CoV-2 5 which is recommended by WHO Moreover, the RBD of the spike protein from SARS-CoV-2 is only one amino acid longer than the RBD of the spike protein from SARS-CoV 8 . As a result, SARS-CoV-2 appears to be optimized for binding to the human receptor ACE2 9 . SARS-CoV-2 seems to have a receptor-binding domain (RBD) that binds with high affinity to ACE2 from humans 9 . Furthermore, relative to SARS-CoV, SARS-CoV-2 S harbors a furin cleavage site at the S1/S2 boundary cleavage by furin-like proteases, which could take part in expanding SARS-CoV-2 cell and tissue tropism, as well as J o u r n a l P r e -p r o o f increasing its transmissibility and/or altering its pathogenicity 10 . The two highly pathogenic CoVs could be transmitted from human to human. It is reported that compared to transmission between relatives occurring in 22-39% of SARS-CoV cases 11 , the transmission route occurs in 57.6% of the total COVID-19 confirmed cases 12, 13 . Taken together, we think that SARS-CoV-2 could be very "crafty" relative to SARS-CoV. Fever, dry cough and fatigue are the most common symptoms of COVID-19 according to previous reports 1, 2, 14, 15 , whereas none of the three patients had fever and the earliest symptoms of Patient 1 were dizziness and diarrhea in the present report. Furthermore, it is different in symptoms of the three patients from a family cluster. Recently, we have already reported several COVID-19 cases with different symptoms from two family clusters. One is a family with three members, of whom two cases did not show any symptoms and one case had fever, sore throat, arthralgia, and myalgia 16 . The other is a family with six members, of whom three cases did not show any symptoms, one case only had a fever, the other two cases were diagnosed as severe COVID-19 17 . Taken together, all of these make the diagnosis of COVID difficult. In sum, it is easily to miss diagnosis of COVID-19 especially for patients with uncommon symptoms, because the virus might be very "crafty". More attention should be paid to observe the clinical characteristics of it and invent more accurate and convenient methods to detect SARS-CoV-2 as soon as possible. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study National Health Commission of the People's Republic of China. Diagnosis and treatment of pneumonitis caused by new coronavirus (trial version 6) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Return of the Coronavirus: 2019-nCoV A new coronavirus associated with human respiratory disease in China The proximal origin of SARS-CoV-2 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein SARS and MERS: recent insights into emerging coronaviruses Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster Clinical and epidemiological features of COVID-19 family clusters in Beijing Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Asymptomatic cases in a family cluster with SARS-CoV-2 infection Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period The present study was funded by Sino-German Center for Research Promotion